NEW YORK (GenomeWeb News) – Interleukin Genetics reported yesterday that its first-quarter revenues declined 30 percent and its net loss rose 32 percent, as its consumer product sales and contract research revenue fell.

The Waltham, Mass.-based genetic test maker brought in total revenues of $1.9 million, down from $2.7 million. Its consumer products sales fell to $1.5 million from $2 million year over year, while its contract research revenues were $203,687 versus $537,013 the year before. The firm's genetic testing service revenue increased to $137,511 from $101,752.